Qube Research & Technologies (QRT)’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.99K Buy
2024
Q1
Sell
2023
Q4
$1.66K Sell
2023
Q3
$16.8K Sell
2023
Q2
$92.6K Buy
2023
Q1
$52.1K Buy
2022
Q4
$39.4K Buy
2022
Q3
Sell
2022
Q2
$75K Buy
2020
Q2
Sell
2020
Q1
$33K Buy